How alarming is post-coital bleeding - A cytologic, colposcopic and histopathologic evaluation

被引:21
作者
Shalini, R
Amita, S
Neera, MA
机构
[1] Guru Teg Bahadur Hosp, Dept Obstet & Gynaecol, Delhi 110095, India
[2] Univ Delhi, Coll Med Sci, Delhi 110007, India
关键词
post-coital bleeding; cervical cytology; colposcopy; ectopy; squamous intra-epithelial lesion; cervical intraepithelial neoplasia;
D O I
10.1159/000009957
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
This retrospective analysis studies post-coital bleeding (PCB) in 110 patients presenting to the colposcopy clinic of the University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi, India, and covers a 2-year period from March 1994 to February 1996. All the patients were evaluated by cytology and colposcopy. Colposcopy-positive patients underwent a directed biopsy. Age, parity and duration of PCB were correlated with histopathologic findings, i.e. benign changes, viral HPV changes and cervical intra-epithelial neoplasia (CIN) 1, CIN 2 and 3 and invasive cancer for risk assessment. 85.5% of the patients had benign findings, 5.6% viral HPV and CIN 1, 3.6% CIN 2 and 3 and 5.5% invasive cancer. Vascular ectopy was the commonest benign colposcopic finding. Cytology had a sensitivity and specificity of 56% and 90%, respectively. The mean age of patients with invasive cancer was 41.3 years versus 32.9 years in patients with benign pathology, the difference being statistically significant (p < 0.05). Mean parity was 4.2 in patients with invasive cancer against 2.8 in benign cases (NS). There was no correlation between duration of bleeding and pathology.
引用
收藏
页码:205 / 208
页数:4
相关论文
共 13 条
[1]  
DAVIS JR, 1981, ACTA CYTOL, V25, P533
[2]  
Ferenczy A, 1996, ACTA CYTOL, V40, P1136
[3]   HOMOGENEOUS SAMPLING ACCOUNTS FOR THE INCREASED DIAGNOSTIC-ACCURACY USING THE THINPREP(TM) PROCESSOR [J].
HUTCHINSON, ML ;
ISENSTEIN, LM ;
GOODMAN, A ;
HURLEY, AA ;
DOUGLASS, KL ;
MUI, KK ;
PATTEN, FW ;
ZAHNISER, DJ .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1994, 101 (02) :215-219
[4]  
MARTIN B, 1995, ACTA CYTOL, V39, P631
[5]  
Nher H, 1991, Hautarzt, V42, P687
[6]  
PARDANANI NS, 1975, NEW YORK STATE J MED, V75, P1018
[7]  
PASINI F, 1991, European Journal of Gynaecological Oncology, V12, P107
[8]   PRESENTATION OF CERVICAL-CANCER [J].
PRETORIUS, R ;
SEMRAD, N ;
WATRING, W ;
FOTHERINGHAM, N .
GYNECOLOGIC ONCOLOGY, 1991, 42 (01) :48-53
[9]  
RUBIO CA, 1981, ACTA CYTOL, V25, P199
[10]  
WEINGOLD AB, 1990, PRINCIPLES PRACTICE, P511